deltatrials
Recruiting NA INTERVENTIONAL 2-arm NCT06541002

A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors (SHIFT)

Multi-Site Randomized Controlled Trial of a Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors

Sponsor: Massachusetts General Hospital

Conditions Bone Marrow Transplant Complications Sexual Dysfunction Stem Cell Transplant Complications
Interventions Enhanced Usual Care Group SHIFT Intervention Group
Updated 2 times since 2024 Last updated: May 20, 2025 Started: Jan 27, 2025 Primary completion: Apr 30, 2029 Completion: Apr 30, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Bone Marrow Transplant Complications and Sexual Dysfunction and is currently actively recruiting participants. Massachusetts General Hospital leads this study, which shows 2 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshotNot Yet Recruiting~Jun 2025 – present · 13 months · monthly snapshotRecruiting

Change History

2 versions recorded

  1. Jun 2025 — Present [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  2. Sep 2024 — Jun 2025 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Massachusetts General Hospital
  • National Cancer Institute (NCI)
Data source: Massachusetts General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations